Zynex Inc Quick Ratio (ZYXI) starting from the third quarter 2025 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Zynex inc   (NASDAQ: ZYXI)

Zynex Inc 's Quick Ratio

ZYXI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2025, Quick Ratio fell to 0.18 below Zynex Inc average.

Within Medical Equipment & Supplies industry 159 other companies have achieved higher Quick Ratio than Zynex Inc in third quarter 2025. While Quick Ratio total ranking in the third quarter 2025 has deteriorated compared to the prior quarter from 2490 to 2714.

Explain Quick Ratio?
How much Cash & cash equivalents ZYXI´s has?
What are ZYXI´s Current Liabilities?




ZYXI Quick Ratio (Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
Y / Y Current Liabilities Change 376.83 % 390.95 % -32.48 % -14.1 % -5.77 %
Y / Y Cash & cash equivalent Change -64.76 % -43.22 % -27.42 % -11.1 % -28.24 %
Quick Ratio MRQ 0.18 0.25 2 3.16 2.41
ZYXI's Total Ranking # 2714 # 2490 # 182 # 501 #
Seq. Current Liabilities Change 7.29 % 480.59 % -4.8 % -19.6 % 10.47 %
Seq. Cash & cash equivalent Change -24.42 % -26.45 % -39.81 % 5.32 % 21.8 %



Quick Ratio third quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 160
Healthcare Sector # 743
Overall Market # 2714


Quick Ratio Statistics
High Average Low
7.41 1.73 0
(Sep 30 2020)   (Dec 31 2015)




Financial Statements
Zynex Inc 's Current Liabilities $ 74 Millions Visit ZYXI's Balance sheet
Zynex Inc 's Cash & cash equivalent $ 13 Millions Visit ZYXI's Balance sheet
Source of ZYXI's Sales Visit ZYXI's Sales by Geography


Cumulative Zynex Inc 's Quick Ratio

ZYXI's Quick Ratio for the trailling 12 Months

ZYXI Quick Ratio

(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 171.25 % 73.77 % -13.87 % -9.58 % -14.8 %
Y / Y Cash & cash equivalent TTM Growth -35.41 % -26.2 % -30.02 % -18.28 % -1.46 %
Quick Ratio TTM 0.56 1.08 2.43 2.35 2.35
Total Ranking TTM # 3367 # 3022 # 752 # 2241 #
Seq. Current Liabilities TTM Growth 53.73 % 101.85 % -9.58 % -3.32 % -1.52 %
Seq. Cash & cash equivalent TTM Growth -20.54 % -10.12 % -6.39 % -3.39 % -9.21 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2025 to $74.41 millions, cumulative Quick Ratio decreased to 0.56 below the Zynex Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 197 other companies have achieved higher Quick Ratio than Zynex Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 3022 to 3367.

Explain Quick Ratio?
How much Cash & cash equivalents ZYXI´s has?
What are ZYXI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 198
Healthcare Sector # 892
Within the Market # 3367


trailing twelve months Quick Ratio Statistics
High Average Low
4.1 1.69 0
(Jun 30 2021)   (June 30. 2016)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Medical Equipment & Supplies Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Adagio Medical Holdings inc   0.48 $ 4.673  Millions$ 9.702  Millions
Lensar Inc   0.47 $ 16.869  Millions$ 35.725  Millions
Strata Skin Sciences Inc  0.47 $ 7.076  Millions$ 15.033  Millions
Star Equity Holdings Inc   0.47 $ 15.368  Millions$ 32.810  Millions
Teleflex Incorporated  0.46 $ 353.997  Millions$ 773.033  Millions
Baxter International Inc   0.46 $ 1,726.000  Millions$ 3,775.000  Millions
Iridex Corp  0.45 $ 5.573  Millions$ 12.392  Millions
Lifeward ltd   0.44 $ 3.912  Millions$ 8.876  Millions
Femasys Inc   0.43 $ 4.569  Millions$ 10.542  Millions
U S Physical Therapy Inc  0.43 $ 31.102  Millions$ 73.120  Millions
Vivos Therapeutics Inc   0.42 $ 3.087  Millions$ 7.437  Millions
Nuo Therapeutics Inc   0.41 $ 0.515  Millions$ 1.257  Millions
Sanuwave Health Inc   0.40 $ 9.602  Millions$ 23.938  Millions
Orthofix Medical Inc   0.39 $ 62.860  Millions$ 159.847  Millions
Semler Scientific inc   0.39 $ 10.446  Millions$ 26.805  Millions
Catheter Precision Inc   0.39 $ 2.056  Millions$ 5.325  Millions
Vivani Medical Inc   0.38 $ 2.628  Millions$ 6.830  Millions
Steris Plc  0.37 $ 319.200  Millions$ 853.600  Millions
Alcon inc   0.37 $ 1,547.000  Millions$ 4,162.000  Millions
Smith and Nephew Plc  0.36 $ 573.000  Millions$ 1,595.000  Millions
Retractable Technologies Inc  0.36 $ 3.445  Millions$ 9.628  Millions
Intelligent Bio Solutions Inc   0.33 $ 1.660  Millions$ 5.062  Millions
Accuray Incorporated  0.33 $ 63.344  Millions$ 194.612  Millions
Adm Tronics Unlimited Inc   0.32 $ 0.321  Millions$ 1.018  Millions
Pavmed Inc   0.31 $ 3.103  Millions$ 9.902  Millions
Integer Holdings Corporation  0.29 $ 58.944  Millions$ 200.696  Millions
Nexgel Inc   0.28 $ 0.938  Millions$ 3.308  Millions
Ss Innovations International Inc  0.27 $ 5.682  Millions$ 21.188  Millions
Milestone Scientific Inc   0.27 $ 1.345  Millions$ 5.034  Millions
Escalon Medical Corp   0.26 $ 0.616  Millions$ 2.341  Millions

Date modified: 2026-09-08T15:11:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.